Drug recall D-1306-2022
Product
Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/12.5 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot no 2, Phase-2, Pharma Zone, SEZ Pithampur, District Dhar, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc,m USA, Mahwah, NJ 07430, NDC 68462-841-13.
Reason for recall
Defective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .
Lots and codes
Lots 17210929 & 17210930, Exp Date 05/2023; Lot 17211203, Exp Date 06/2023 & Lots 17211643, 17211646 & 17211649, Exp Date 08/2023
Recall details
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ
- Distribution
- nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- June 29, 2022
- Terminated
- June 27, 2024
Related products
- Telmisartan And Hydrochlorothiazide – drug information
- NDC 68462-841 Telmisartan and Hydrochlorothiazide · Telmisartan 80 mg/1; Hydrochlorothiazide 12.5 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-840 Telmisartan and Hydrochlorothiazide · Telmisartan 40 mg/1; Hydrochlorothiazide 12.5 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-842 Telmisartan and Hydrochlorothiazide · Telmisartan 80 mg/1; Hydrochlorothiazide 25 mg/1 · Glenmark Pharmaceuticals Inc., USA